Skip to main content
. 2017 Jan 27;12(1):e0170729. doi: 10.1371/journal.pone.0170729

Table 2. Summary of results yielded under fixed-effect and random-effects models.

Outcomes No. of trials Fixed-effect model Random-effects model Heterogeneity
Effect size 95% CI P value Effect size 95% CI P value P value I2
DGF 6 0.84 0.60–1.18 0.32 0.89 0.61–1.28 0.52 0.40 3%
AR 4 0.95 0.62–1.46 0.81 0.96 0.62–1.49 0.86 0.51 0%
Graft loss 4 0.89 0.35–2.27 0.81 0.90 0.32–2.52 0.84 0.40 0%
50% fall in SCr 3 1.05 0.84–1.30 0.68 1.05 0.70–1.57 0.81 0.03 70%
eGFR 3m 4 1.23 -1.73–4.19 0.41 1.23 -1.73–4.19 0.41 0.61 0%
eGFR 12m 2 3.35 -1.49–8.19 0.18 3.01 -3.26–9.29 0.35 0.21 37%
Hospital stay 4 -0.73 -1.56–0.11 0.09 -0.73 -1.56–0.11 0.09 0.46 0%

DGF: delayed graft function; AR: acute rejection; SCr: serum creatinine; eGFR: estimated glomerular filtration rate; CI: confidence interval.